MDXHEALTH
MDXHNASDAQ🏆 #3557 by market capUS Equity
$333.04▲ $26.01 (+7.81%)
Simulated price1h—
24h▲ 7.8%
7d—
14d—
30d—
1y—
🏦Market Cap
$23M
Small Cap
📈Revenue Growth (YoY)
+18.2%
Healthy
📊Gross Margin
64.0%
High
💵FCF Margin
—
⚖️P/S Ratio
0.1x
Cheap
Otter Score
65
Fair
No chart data available for MDXH.
Trading Snapshot
- Day Range
- $328.88 – $337.29
- 52-Week Range
- $0.40 – $5.33
- Volume
- $2.86B
- Avg Volume
- $3.21B
- Shares Outstanding
- 51.4M
- Next Earnings
- Sep 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $153M
- Last Q Revenue
- $41M
- P/E Ratio
- —
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-1.00
- Dividend Yield
- —
Why Investors Own MDXH
- ✓High-growth profile — revenue up -6.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 51% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$153M▼ −2.1% YoY
Gross Margin (TTM)
51.0%▼ −0.1% YoY
Operating Income (TTM)
$15M▼ −2.1% YoY
Free Cash Flow (TTM)
$19M▼ −2.1% YoY
About MDXHEALTH
A company profile for MDXHEALTH isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
65/100
Analyst Price Target
ⓘAverage Target
$445.68
▲ +33.8% Upside
High Target$534.56
Low Target$412.73
Based on 30 analysts
Latest News & Updates
🚀
CNBC·2h ago
MDXHEALTH tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift MDXH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
MDXHEALTH announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.